BMGL (Basel Medical Group Ltd Ordinary Shares) Stock Analysis - Financials

Basel Medical Group Ltd Ordinary Shares (BMGL) is a publicly traded Healthcare sector company. As of May 21, 2026, BMGL trades at $0.63 with a market cap of $12.39M and a P/E ratio of 0.00. BMGL moved +0.00% today. Year to date, BMGL is +9.49%; over the trailing twelve months it is -67.59%. Its 52-week range spans $0.49 to $9.40. Rallies surfaces BMGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are BMGL's key financials?

BMGL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BMGL recently traded at $0.63. Market cap is $12.39M. P/E ratio is 0.00. Revenue is $0.

BMGL Key Metrics

Key financial metrics for BMGL
MetricValue
Price$0.63
Market Cap$12.39M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$9.40
52-Week Low$0.49
Volume2
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest BMGL News

BMGL Analyst Consensus

BMGL analyst coverage data. Average price target: $0.00.

Common questions about BMGL

What are BMGL's key financials?
BMGL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BMGL recently traded at $0.63. Market cap is $12.39M. P/E ratio is 0.00. Revenue is $0.
Is BMGL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BMGL. It does not provide personalized investment advice.
BMGL

BMGL